Suppr超能文献

老年人 COVID-19 临床管理现状综述。

A Review of the Current Status of Clinical Management of COVID-19 in the Elderly.

机构信息

Graduate School, Qinghai University, Xining, Qinghai, China (mainland).

Department of Geriatrics, Affiliated Hospital of Qinghai University, Xining, Qinghai, China (mainland).

出版信息

Med Sci Monit. 2021 Apr 9;27:e930278. doi: 10.12659/MSM.930278.

Abstract

The high infectivity and severity of SARS-CoV-2 infection (COVID-19), and our limited understanding of the biology of the novel coronavirus, as well as the lack of an effective treatment for COVID-19, have created a global pandemic. Those most likely to become seriously ill with COVID-19 are adults, especially the elderly and those who are already weak or sick. At present, a specific drug for treatment of COVID-19 has not been developed. This, combined with the typical coexistence of a variety of chronic diseases in elderly patients, makes treatment challenging at present. In addition, for elderly patients, COVID-19 isolation measures during the epidemic can easily lead to psychological problems. Thus, how to manage elderly patients has become a focus of social attention in the current circumstances. This article reviews the effects of COVID-19 and makes management suggestions for elderly patients during this epidemic period. In addition to the elderly, critically ill people are also highly susceptible to this novel coronavirus. For elderly COVID-19 patients, antiviral therapy, immune regulation, and even auxiliary respiratory therapy can be given after a comprehensive evaluation of the disease. With the approval and use of COVID-19 vaccines, it is reasonable to expect that we can conquer SARS-CoV-2.

摘要

SARS-CoV-2 感染具有高传染性和严重性(COVID-19),而我们对新型冠状病毒的生物学特性了解有限,以及缺乏有效的 COVID-19 治疗方法,这些因素共同导致了全球大流行。最有可能因 COVID-19 而病重的是成年人,尤其是老年人和那些已经虚弱或患病的人。目前,尚未开发出用于治疗 COVID-19 的特定药物。再加上老年患者通常同时存在多种慢性疾病,这使得目前的治疗极具挑战性。此外,对于老年患者来说,大流行期间的 COVID-19 隔离措施很容易导致心理问题。因此,如何管理老年患者已成为当前情况下社会关注的焦点。本文回顾了 COVID-19 的影响,并针对老年患者在这一流行期间提出了管理建议。除了老年人,危重症患者也极易感染这种新型冠状病毒。对于老年 COVID-19 患者,可以在对疾病进行全面评估后,给予抗病毒治疗、免疫调节,甚至辅助呼吸治疗。随着 COVID-19 疫苗的批准和使用,我们有望战胜 SARS-CoV-2。

相似文献

7
A detailed review of the outbreak of COVID-19.对 COVID-19 疫情爆发的详细回顾。
Front Biosci (Landmark Ed). 2021 May 30;26(6):149-170. doi: 10.52586/4931.

引用本文的文献

本文引用的文献

4
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.mRNA-1273 新型冠状病毒疫苗的有效性和安全性。
N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30.
7
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
8
Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions.SARS-CoV-2 和 SARS-CoV 抗体相互作用的结构基础。
Trends Immunol. 2020 Nov;41(11):1006-1022. doi: 10.1016/j.it.2020.09.004. Epub 2020 Sep 17.
9
Mitochondria: In the Cross Fire of SARS-CoV-2 and Immunity.线粒体:处于新冠病毒与免疫的交叉火力之下
iScience. 2020 Oct 23;23(10):101631. doi: 10.1016/j.isci.2020.101631. Epub 2020 Sep 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验